Jul 2026· Revista Brasileira de Cancerologia· Vol 72, pp. e115536· 0 citations· 29 references
TL;DR
It is demonstrated that vapes are capable of activating carcinogenic pathways in head and neck cells and oral mucosa, creating a microenvironment favorable to neoplastic initiation, promotion, and progression.
Abstract
Introduction: The increased use of electronic cigarettes (vapes) has been identified as a new public health problem. Objective: To find evidence on the effects of vaping on the establishment of cellular and tissue damage and to identify carcinogenic pathways related to head and neck cancer and oral cancer. Method: Systematic review research in the PubMed, LILACS, SciELO, and Cochrane databases, with a ten-year time frame (2014-2024). Descriptors: e-cigarettes, vaping, oral cancer, squamous carcinoma, and head & neck cancer. Fourteen original in vitro and in vivo studies that investigated alterations at the molecular and clinical level resulting from exposure to and consumption of vapes were included and analyzed. The studies were classified according to the risk of bias using the OHAT and ROBINS-E tools. Results: Findings were grouped by the predominance of genotoxic and cytotoxic effects, as well as alterations in inflammatory pathways and cell progression and tissue lesions in the oral mucosa. In vitro and in vivo results showed DNA damage, micronucleus formation, reduced cell viability, increased LDH and ROS, activation of oncogenic pathways such as NF-κB and STAT3, and inflammatory pathways (increased interleukins) and progression pathways (epithelial-mesenchymal transition phenotype). Conclusion: Together, the findings demonstrate that vapes are capable of activating carcinogenic pathways in head and neck cells and oral mucosa. In addition, we consider activating and accelerating inflammatory processes, creating a microenvironment favorable to neoplastic initiation, promotion, and progression. These findings highlight the need for more robust clinical studies and mechanistic investigations focused on agent-speciftradic pathways.
The need for strict regulation of the distribution and use of ENDS at the legislative level is beyond doubt, as ENDS has been shown to induce epithelial-mesenchymal transition in various types of cancer cells.
V. Vasilyev, I. Moiseeva, Evgeniy A. Gusev· University proceedings Volga...· 0 citations
The aim of this review is to determine the effect of alternative tobacco/nicotine products on response to chemotherapy, including mechanistic toxicology evidence, treatment-resistance signals and potential hazard. The literature was searched in PubMed, Embase and Web of Science databases in June 2026. Currently, there...
P. Kopa-Stojak, Rafał Pawliczak· Toxicology Mechanisms and Me...· 0 citations
Electronic cigarette and heated-tobacco emissions may contain nicotine, ultrafine particles, carbonyls, volatile organic compounds, metals, and thermal degradation products that should not be considered harmless.
A. Akcan, Derya Pekşen Akcan· Uluslararası Sağlık Bilimler...· 0 citations
Overall, changes in some blood parameters were possibly a response to the sensory irritation of FA in the upper respiratory tract, and it is recommended that the exposure of workers to FA be evaluated in a more comprehensive way by following well-validated FA sampling and analysis methods in future studies to better el...
Reza Pourbabaki, Fatemeh Rahimian, M. Ghaffari et al.· Toxicology and industrial he...· 0 citations
Evidence regarding the effects of vanadium in human populations is limited; nevertheless, the available reports substantiate its potential harmful effects on fetal development and various human systems.
Thalía O Macías-Camacho, M. Sánchez-Rodríguez· Critical Reviews in Toxicolo...· 0 citations
No form of nicotine delivery is neutral with respect to periodontal health, and patients using both conventional and alternative nicotine products should be regarded as a group at increased risk for periodontal disease.
Gabriela Czerepak, Aleksandra Jędras, K. Bednarz et al.· Quality in Sport· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.